MRK

[$$] Bayer Bulks Up Its Medicine Chest With Merck Brands

[at The Wall Street Journal] – Merck agreed to sell its consumer-care business, including the allergy-treatment Claritin and nasal decongestant Afrin, to Bayer for $14.2 billion. moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]

[$$] Overheard

[at The Wall Street Journal] – Talk about a case of mistaken corporate identity. Once again, Merck KGaA, the Darmstadt, Germany-based supplier of high-tech products for the pharmaceuticals and chemicals sectors was getting confused … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to […]

[$$] Overheard

[at The Wall Street Journal] – Talk about a case of mistaken corporate identity. Once again, Merck KGaA, the Darmstadt, Germany-based supplier of high-tech products for the pharmaceuticals and chemicals sectors was getting confused … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to […]

[$$] Bayer Bulks Up Its Medicine Chest With Merck Brands

[at The Wall Street Journal] – Merck agreed to sell its consumer-care business, including the allergy-treatment Claritin and nasal decongestant Afrin, to Bayer for $14.2 billion. moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]

How Bayer’s Buy Makes Sense

moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]